Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Current Leases (2019 - 2025)

Historic Current Leases for Harvard Bioscience (HBIO) over the last 7 years, with Q3 2025 value amounting to $1.5 million.

  • Harvard Bioscience's Current Leases rose 3185.45% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 3185.45%. This contributed to the annual value of $1.2 million for FY2024, which is 1822.03% down from last year.
  • As of Q3 2025, Harvard Bioscience's Current Leases stood at $1.5 million, which was up 3185.45% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Current Leases ranged from a high of $2.2 million in Q1 2022 and a low of $1.1 million during Q2 2024
  • For the 5-year period, Harvard Bioscience's Current Leases averaged around $1.8 million, with its median value being $2.1 million (2021).
  • In the last 5 years, Harvard Bioscience's Current Leases plummeted by 5021.18% in 2024 and then soared by 3733.46% in 2025.
  • Harvard Bioscience's Current Leases (Quarter) stood at $2.1 million in 2021, then fell by 0.33% to $2.1 million in 2022, then plummeted by 33.68% to $1.4 million in 2023, then dropped by 18.22% to $1.2 million in 2024, then increased by 28.32% to $1.5 million in 2025.
  • Its Current Leases stands at $1.5 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.4 million for Q1 2025.